RA monocytes show activation of PI3K/mTOR and MAPK pathways, inhibition of mTOR reduces synovial osteoclast formation and protects against local bone and cartilage damage (72), highlighting the central role of cytokine-driven signaling in RA pathophysiology. This evidence concerns the gene MTOR and rheumatoid arthritis.